Therapeutic Asset Ratings

6,299 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Dasatinib Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia	Princess Maxima Center for Pediatric Oncology	P1/2	CC (45)
Dasatinib Metabolic Dysfunction-Associated Steatotic Liver Disease	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	P1/2	CC (45)
Dasatinib Peripheral T-Cell Lymphoma, Not Otherwise Specified	Ruijin Hospital	P1/2	CC (45)
db-1310 Cancer	Synnovation Therapeutics, Inc.	P1/2	CC (45)
Dcsz11 Head And Neck Squamous Cell Carcinoma	West China Hospital	P1/2	CC (45)
Decitabine Acute Undifferentiated Leukemia	Fred Hutchinson Cancer Center	P1/2	CC (45)
Decitabine Precursor B-Cell Acute Lymphoblastic Leukemia	Princess Maxima Center for Pediatric Oncology	P1/2	CC (45)
Decoy20 Colorectal Cancer	Indaptus Therapeutics, Inc	P1/2	CC (45)
Defactinib Glioblastoma	Institute of Cancer Research, United Kingdom	P1/2	CC (45)
Deoxycholic Acid Primary Peritoneal Carcinoma	THERAPIM PTY LTD	P1/2	CC (45)
Deuterated Water Obesity Disorder	Columbia University	P1/2	CC (45)
Dexasone Large Intestine Disorder	University of Saskatchewan	P1/2	CC (45)
Dexasone Oropharyngeal Carcinoma	National Cancer Institute (NCI)	P1/2	CC (45)
Dexasone Head And Neck Squamous Cell Carcinoma	Takeda	P1/2	CC (45)
Dexasone Triple-Negative Breast Carcinoma	Andrew Hantel, MD	P1/2	CC (45)
Dna (Recombinant Replication-Deficient Adeno-Associated Virus 5 Vector Amt-130 Chicken .Beta.-Actin Promoter Plus Human Huntingtin Mrna-Targeting Microrna Mihtt-Specifying) Huntington Disease	UniQure Biopharma B.V.	P1/2	CC (45)
Domvanalimab Pancreatic Adenocarcinoma	James Cleary, MD, PhD	P1/2	CC (45)
Dostarlimab Ependymoma	GlaxoSmithKline	P1/2	CC (45)
Dostarlimab Fibrolamellar Hepatocellular Carcinoma	GlaxoSmithKline	P1/2	CC (45)
Dostarlimab Plasma Cell Myeloma	GlaxoSmithKline	P1/2	CC (45)
Dostarlimab Osteosarcoma	GlaxoSmithKline	P1/2	CC (45)
Dostarlimab Female Reproductive System Neoplasm	GlaxoSmithKline	P1/2	CC (45)
DS3790a B-Cell Non-Hodgkin Lymphoma	Daiichi Sankyo	P1/2	CC (45)
Dual-Target Antigen-Selected Car-Nk Acute Myeloid Leukemia	Essen Biotech	P1/2	CC (45)
Dual-Target Antigen-Selected Car-Nk Cutaneous Melanoma	Essen Biotech	P1/2	CC (45)

Showing 3501 to 3525 of 6,299 assets

PreviousPage 141 of 252Next